Name | pvalue | Ratio |
---|---|---|
Top canonical pathways | Â | Â |
GABA receptor signaling | 1.66E-02 | 1/67 |
Renal cell carcinoma signaling | 1.75E-02 | 1/71 |
Toll-like receptor signaling | 1.83E-02 | 1/74 |
Hereditary breast cancer signaling | 2.83E-02 | 1/115 |
RhoA signaling | 3.00E-02 | 1/122 |
Top disease and biological functions | ||
Cardiovascular disease | 2.49E-04 ~ 3.94E-02 | |
Developmental disorder | 2.49E-04 ~ 3.94E-02 | |
Hereditary disorder | 2.49E-04 ~ 1.24E-03 | |
Organismal injury and abnormalities | 2.49E-04 ~ 3.94E-02 | |
Skeletal and muscular disorders | 2.49E-04 ~ 3.94E-02 | |
Physiological system development and function | ||
Embryonic development | 6.94E-05 ~ 4.35E-02 | |
Organismal development | 9.92E-05 ~ 4.35E-02 | |
Cardiovascular system development and function | 4.98E-04 ~ 3.85E-02 | |
Hematological system development and function | 4.98E-04 ~ 1.48E-02 | |
Hepatic system development and function | 4.98E-04 ~ 3.00E-02 |